You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Vaxzevria

Showing 1 - 22 of 22
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

(PMS) for the Long-term Safety of VAXZEVRIA

Active, not recruiting
  • Prevention of Infectious Disease Caused by SARS-CoV-2
    • Chiba, Japan
    • +5 more
    Nov 24, 2022

    SARS-CoV-2 Infection Trial (PTX-COVID19-B, Vaxzevria®)

    Not yet recruiting
    • SARS-CoV-2 Infection
    • PTX-COVID19-B
    • Vaxzevria®
    • (no location specified)
    Sep 7, 2022

    (PMS) for Underlying Disease at High-risk for Worsening COVID-19

    Recruiting
    • Prevention of Infectious Disease Caused by SARS-CoV-2
      • Akita, Japan
      • +9 more
      Feb 1, 2023

      Active, not recruiting
      • Covid19
      • Baracaldo, Bizkaia, Spain
      • +4 more
      May 17, 2022

      COVID-19 Trial in Bandung (Pfizer-BioNTech Standard dose, AstraZeneca Standard dose, Pfizer-BioNTech Fractional dose)

      Not yet recruiting
      • COVID-19
      • Pfizer-BioNTech Standard dose
      • +5 more
      • Bandung, West Java, Indonesia
      • +2 more
      Nov 30, 2022

      SARS-CoV2 Infection Trial in Innsbruck (Vaxzevria, Comirnaty)

      Recruiting
      • SARS-CoV2 Infection
      • Vaxzevria
      • Comirnaty
      • Innsbruck, Tyrol, Austria
        Medical University of Innsbruck
      Sep 9, 2021

      Adaptive Immune Response to COVID-19 Vaccination

      Active, not recruiting
      • SARS-CoV-2 Vaccination
      • Greifswald, MV, Germany
        University Medicine Greifswald
      Mar 25, 2022

      SafeTy and Efficacy of Preventative CoVID Vaccines

      Active, not recruiting
      • COVID-19 Virus Infection
      • Vaccine Response
      • mRNA Vaccines or Viral vector-based vaccines for COVID
      • Toronto, Ontario, Canada
        University Health Network
      May 19, 2022

      Does Repeat Influenza Vaccination Constrain Influenza Immune

      Recruiting
      • Influenza, Human
      • SARS-CoV-2 Infection
      • Influenza vaccination: Fluarix Tetra, Vaxigrip Tetra, Fluquadri, Fluad Quad, Afluia Quad, Flucelvax Quad
      • SARS-CoV-2 vaccination: Comirnaty or Vaxzevria
      • New Lambton Heights, New South Wales, Australia
      • +5 more
      Nov 7, 2022

      Following COVID-19 Vaccination in Patients With Down Syndrome.

      Recruiting
      • Down Syndrome
      • SARS-CoV-2 Vaccination
      • Immune response to Sars-CoV-2 vaccinations; including COVID-19 vaccin Moderna, Comirnaty (Pfizer) and Vaxzevria (AstraZeneca)
      • Utrecht, Netherlands
        UMC utrecht
      Dec 9, 2021

      Covid19 Trial in Baracaldo, Barcelona, Madrid (COMIRNATY)

      Active, not recruiting
      • Covid19
      • Barakaldo, Vizkaia, Spain
      • +4 more
      May 1, 2021

      Covid19 Trial in Cairo (Astrazeneca/Oxford Vaccine, Sinopharm vaccine)

      Recruiting
      • Covid19
      • Astrazeneca/Oxford Vaccine
      • Sinopharm vaccine
      • Cairo, Non-US, Egypt
        Faculty of Medicine Ain Shams University Research Institute- Cli
      May 8, 2021

      COVID-19 Trial in Canada (mRNA-1273 SARS-CoV-2 vaccine, BNT162b2, ChAdOx1-S [recombinant])

      Recruiting
      • COVID-19
      • mRNA-1273 SARS-CoV-2 vaccine
      • +4 more
      • Edmonton, Alberta, Canada
      • +7 more
      Mar 7, 2022

      COVID-19 Trial in Melbourne (Tozinameran, Elasomeran, Bivalent Pfizer-BioNTech)

      Not yet recruiting
      • COVID-19
      • Tozinameran
      • +3 more
      • Melbourne, Victoria, Australia
        Royal Children's Hospital, Murdoch Children's Research Institute
      Sep 14, 2022

      COVID-19 Trial in Melbourne (Tozinameran - Standard dose, Tozinameran - fractional dose, Elasomeran - standard dose)

      Active, not recruiting
      • COVID-19
      • Tozinameran - Standard dose
      • +3 more
      • Melbourne, Victoria, Australia
        Royal Children's Hospital
      Aug 24, 2022

      Vaccination Reaction, COVID-19, Vaccination; Infection Trial in Cologne (Comirnaty(BTN162b2), Spikevax (mRNA-1273))

      Recruiting
      • Vaccination Reaction
      • +2 more
      • Comirnaty(BTN162b2)
      • Spikevax (mRNA-1273)
      • Cologne, Germany
        University Hospital Cologne
      Jan 27, 2022

      COVID-19 Trial in Groningen (AKS-452X)

      Recruiting
      • COVID-19
      • AKS-452X
      • Groningen, Netherlands
        University Medical Center Groningen
      May 19, 2022

      Immunogenicity of Covid-19 Vaccination for Hematological

      Active, not recruiting
      • Immunogenicity
      • +3 more
        • Varese, Lombardia, Italy
          UOC Ematologia, ASST Sette Laghi, Osp. Di Circolo e Fondazione M
        Sep 10, 2021

        Vaccination Against COVID-19 in Pregnant and Lactating Belgium

        Active, not recruiting
        • Covid19
        • COVID-19 vaccine
        • Antwerp, Belgium
          Centre for the Evaluation of Vaccination
        Nov 15, 2022

        Menstrual Irregularities and Abnormal Uterine Bleeding After

        Completed
        • COVID-19
        • +3 more
        • Covid-19 vaccine
        • Varese, Italy
          University of Insubria
        Oct 31, 2022

        COVID-19, SARS-CoV-2 Acute Respiratory Disease Trial in Italy, Portugal, Spain (COVID-19 Vaccine 40 ug/dose)

        Recruiting
        • COVID-19
        • SARS-CoV-2 Acute Respiratory Disease
        • COVID-19 Vaccine 40 ug/dose
        • Milano, Italy
        • +19 more
        Jul 19, 2022

        COVID-19 Vaccines Safety Tracking (CoVaST)

        Recruiting
        • Adverse Reaction to Vaccine
        • COVID19 Vaccine
        • BNT162b2
        • +9 more
        • Philadelphia, Pennsylvania
        • +13 more
        Apr 5, 2022